Endocrine Community Makes Progress in Advancing EU EDC Regulations

In recent weeks, organizations around the world have intensified their lobbying efforts for better regulation of endocrine-disrupting chemicals (EDCs) and the Endocrine Society’s members continue to play a leading role as the voice of science in high-level discussions.

In the European Union, the Commission is under a tight deadline to deliver reforms to the regulation on Registration, Evaluation, Authorisation, and Restriction of Chemicals (REACH), which governs restrictions on EDCs. To ensure prioritization of this reform we partnered with the European Society of Endocrinology (ESE) to organize a petition to Commission President Ursula von der Leyen emphasizing the urgent need to deliver a legislative proposal to revise REACH by June 2023. The petition was co-signed by 44 European and international endocrine-focused scientific societies and delivered to members of the European Parliament and other policymakers with an interest in EDCs. The petition generated significant attention and was reported on by Politico EU noting our “United Front.”

Organizations around the world have intensified their lobbying efforts for better regulation of endocrine-disrupting chemicals and the Endocrine Society’s members continue to play a leading role as the voice of science in high-level discussions.

Additionally, we signed a letter organized by the European Environment Bureau and supported by 11 other members of a high-level strategic advisory group on chemicals and sustainability to urge the European Commissioner for the Internal Market, Thierry Breton, to support a prompt revision of REACH to ensure harmonized and predictable regulatory approaches to chemicals, including EDCs, across the EU. Reforms to the REACH regulation are necessary to ensure that new regulatory classes that identify hazardous EDCs can be implemented to reduce exposure to these harmful chemicals.

You may also like

  • Endocrine Society Weighs in on MPFS; Urges Congress to Avert Scheduled Medicare Cuts

    Each year, the Center for Medicare and Medicaid Services (CMS) releases the Medicare Physician Fee Schedule (MPFS) rule, which outlines the agency’s payment and quality program policies for the upcoming year. Medicare policy often sets the bar for the private insurance market as well. Therefore, the payment policies and other revisions in the MPFS are…

  • Endocrine Society Urges Congress to Complete NIH Appropriations by December 16th Deadline

    The Endocrine Society is committed to advocating for increases in the budget of the National Institutes of Health (NIH). Our Hill days, advocacy campaigns, and meetings with appropriators have contributed to increases in the NIH budget over the past seven years. Continued investment in the NIH is critical to further our understanding of endocrine disorders…